Author information:
(1)Department of Neuroscience and Pathobiology, Research Institute of 
Environmental Medicine, Nagoya University, Nagoya, Japan.
(2)Laboratory for Motor Neuron Disease, RIKEN Brain Science Institute, Wako, 
Japan.
(3)Department of Neurology, Graduate School of Medicine, Kyoto University, 
Kyoto, Japan.
(4)Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science 
Institute, Wako, Japan.
(5)Department of Cell Biology and Neuroscience, Juntendo University Graduate 
School of Medicine, Tokyo, Japan.
(6)Division of Pharmacology, Faculty of Pharmacy, Keio University, Tokyo, Japan.
(7)Department of Mucosal Immunology, School of Medicine, Chiba University, 
Chiba, Japan.
(8)Division of Innate Immune Regulation, International Research and Development 
Center for Mucosal Vaccines, Institute of Medical Science, The University of 
Tokyo, Tokyo, Japan.
(9)Laboratory of Host Defense, World Premier International Immunology Frontier 
Research Center, and Department of Host Defense, Research Institute for 
Microbial Diseases, Osaka University, Osaka, Japan.
(10)Department of Cellular and Molecular Neuropathology, Juntendo University 
Graduate School of Medicine, Tokyo, Japan.
(11)Department of Neuroscience and Pathobiology, Research Institute of 
Environmental Medicine, Nagoya University, Nagoya, Japan. 
kojiyama@riem.nagoya-u.ac.jp.
(12)Laboratory for Motor Neuron Disease, RIKEN Brain Science Institute, Wako, 
Japan. kojiyama@riem.nagoya-u.ac.jp.
(13)Department of Neuroscience and Pathobiology, Nagoya University Graduate 
School of Medicine, Nagoya, Japan. kojiyama@riem.nagoya-u.ac.jp.